Anti-Human IGF-BP1

Grouped product items
SizePrice Qty
Catalog Number : 500-P228


Produced from sera of rabbits immunized with highly pure recombinant Human IGF-BP1. Anti-Human IGF-BP1 specific antibody was purified by affinity chromatography employing an immobilized Human IGF-BP1 matrix.

Additional Information

Application:ELISA, Western Blot, Immunohistochemistry
Anti-Human IGF-BP1 (BioGems Catalog #350-10)
Polyclonal Rabbit
This antibody stained formalin-fixed, paraffin-embedded sections of human normal placenta.  The recommended concentration is 0.125 µg/mL- 0.200 µg/mL with an overnight incubation at 4˚C.  An HRP-labeled polymer detection system was used with a DAB chromogen.  Heat induced antigen retrieval with a pH 6.0 sodium citrate buffer is recommended.  Optimal concentrations and conditions may vary.    Tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute. 
Sandwich ELISA:
To detect hIGF-BP1 by sandwich ELISA (using 100μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with BioGems' Biotinylated Anti-Human IGF-BP1 (60-188BT) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIGF-BP1.
Western Blot:
To detect hIGF-BP1 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-BP1 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
© BioGems International, Inc. All rights reserved.